SG

Shashi Gupta

Active Director Director DIN 07018233
DIN 07018233 First appointment Nov 2014 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2014
Shareholding value •••• Premium profile

About Shashi Gupta

Data last updated:

Shashi Gupta is a Director at Pinakin Pharmaceuticals Private Limited (since 2014). The company operates in Trading. Pinakin Pharmaceuticals Private Limited reported revenue of ₹19 Lakh (FY 2024).

DIN 07018233
Primary Designation Director
Industry Trading
First Appointment 13 Nov 2014
Oldest Company Age 12 yrs
Largest company Pinakin Pharmaceuticals Private Limited · ₹19 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Nov 20142014₹19 Lakh (FY 2024)Active

Board colleagues of Shashi Gupta

Directorship timeline

Open interactive timeline →
Pinakin Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shashi Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shashi Gupta

Shashi Gupta currently holds 1 directorship: Pinakin Pharmaceuticals Private Limited (Director, since 13 Nov 2014, revenue ₹19 Lakh (FY 2024)).

Shashi Gupta was first appointed on 13 Nov 2014 as Director at Pinakin Pharmaceuticals Private Limited.

The current boards of Shashi Gupta's companies include Ankit Gupta (Pinakin Pharmaceuticals Private Limited), Jyoti Gupta (Pinakin Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available